CO4950614A1 - Antagonistas de taquiquinina - Google Patents

Antagonistas de taquiquinina

Info

Publication number
CO4950614A1
CO4950614A1 CO98001002A CO98001002A CO4950614A1 CO 4950614 A1 CO4950614 A1 CO 4950614A1 CO 98001002 A CO98001002 A CO 98001002A CO 98001002 A CO98001002 A CO 98001002A CO 4950614 A1 CO4950614 A1 CO 4950614A1
Authority
CO
Colombia
Prior art keywords
compound
formula
production
acid addition
addition salt
Prior art date
Application number
CO98001002A
Other languages
English (en)
Spanish (es)
Inventor
Walpole Christopher Simon John
Mahavir Prashad
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4950614A1 publication Critical patent/CO4950614A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/22Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO98001002A 1997-01-14 1998-01-13 Antagonistas de taquiquinina CO4950614A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700597.9A GB9700597D0 (en) 1997-01-14 1997-01-14 Organic compounds

Publications (1)

Publication Number Publication Date
CO4950614A1 true CO4950614A1 (es) 2000-09-01

Family

ID=10805904

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98001002A CO4950614A1 (es) 1997-01-14 1998-01-13 Antagonistas de taquiquinina

Country Status (14)

Country Link
US (1) US6107293A (https=)
EP (1) EP0964867B1 (https=)
JP (2) JP4306804B2 (https=)
AR (1) AR011521A1 (https=)
AT (1) ATE290546T1 (https=)
AU (1) AU5764298A (https=)
CA (1) CA2278057C (https=)
CO (1) CO4950614A1 (https=)
DE (1) DE69732715T2 (https=)
ES (1) ES2239368T3 (https=)
GB (1) GB9700597D0 (https=)
PT (1) PT964867E (https=)
WO (1) WO1998031704A2 (https=)
ZA (1) ZA98256B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426331B1 (en) 1998-07-08 2002-07-30 Tularik Inc. Inhibitors of STAT function
GB9815696D0 (en) * 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics
EP1158996A4 (en) 1999-02-18 2005-01-12 Kaken Pharma Co Ltd NEW AMIDE SECRETAGOGUES OF GROWTH HORMONE DERIVATIVES
WO2001083517A1 (en) * 2000-05-03 2001-11-08 Tularik Inc. Stat4 and stat6 binding dipeptide derivatives
US6884782B2 (en) 2000-11-08 2005-04-26 Amgen Inc. STAT modulators
US20070219214A1 (en) * 2006-02-01 2007-09-20 Solvay Pharmaceuticals Gmbh Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
US8426386B2 (en) 2006-10-16 2013-04-23 Lion Corporation NK1 receptor antagonist composition
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
CN111918647A (zh) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 用于治疗眼痛的nk-1拮抗剂
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
FR2719312B1 (fr) * 1994-04-28 1996-06-14 Adir Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DE69732715T2 (de) 2006-04-13
JP3817256B2 (ja) 2006-09-06
JP2000516257A (ja) 2000-12-05
WO1998031704A3 (en) 1998-09-11
ZA98256B (en) 1998-07-14
ES2239368T3 (es) 2005-09-16
PT964867E (pt) 2005-07-29
AR011521A1 (es) 2000-08-30
CA2278057C (en) 2004-05-04
DE69732715D1 (de) 2005-04-14
ATE290546T1 (de) 2005-03-15
EP0964867A2 (en) 1999-12-22
JP2006089499A (ja) 2006-04-06
AU5764298A (en) 1998-08-07
CA2278057A1 (en) 1998-07-23
WO1998031704A2 (en) 1998-07-23
JP4306804B2 (ja) 2009-08-05
US6107293A (en) 2000-08-22
EP0964867B1 (en) 2005-03-09
GB9700597D0 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
ES8707926A1 (es) Un procedimiento para preparar peroxiacidos organicos de alquilo o alcalino de c6-c20 sustituidos con heteroatomos.
AR246433A1 (es) Un procedimiento para desinfectar un substrato.
ES2059395T3 (es) Composiciones blanqueadoras, peracidos de esteres glicolicos y precursores.
ES2051719T3 (es) Un procedimiento para producir un compuesto de benzoilurea.
PE1998A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
CO4950614A1 (es) Antagonistas de taquiquinina
AR248018A1 (es) Procedimiento para preparar compuestos de (1h)-bencimidazol-2-il-piperidinilmetanona.
DK1463487T3 (da) Liposomal afgivelse af vitamin-E baserede forbindelser
ES2051843T3 (es) Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico.
ES2062486T3 (es) 3-fenilbenzofuran-2-onas.
ES8401026A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos.
ES2007543A6 (es) Procedimiento de preparacion de 1,4-dihidropiridinas.
NO20025054D0 (no) Oksidasjonsprosess for fremstilling av mellomproduktet 6.alfa., 9.alfa.-difluor-11.beta., 17.alfa.-dihydroksy-16.alfa.-metyl-androst-1,4-dien-3-on 17.beta.-karboksylsyre
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
PE22491A1 (es) Compuesto de imidazol y composiciones para el tratamiento de textiles que lo contienen
AR015369A1 (es) Composiciones aditivas de lavanderia que se activan en el secarropas y provistas con agentes protectores del color, articulos de lavanderia que lascontienen y metodo para lavar
CO4980887A1 (es) Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES8202001A1 (es) Procedimiento de producir dihidropiridinas n-morfolinoalqui-licas
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES8703424A1 (es) Procedimiento para la obtencion de compuestos de amida
ES2098219T3 (es) Compuestos de purina y su preparacion.
CO4890847A1 (es) Compuestos de piridiloxi
ES2189184T3 (es) Mezclas fungicidas.